Tweet
Los Angeles Times
<img alt="" height="1" width="1" />
Pfizer's Aromasin cuts breast cancer risk in half
San Francisco Chronicle
Millions of women at higher-than-usual risk of breast cancer have a new option for preventing the disease. Pfizer Inc.'s Aromasin cut the risk of developing breast cancer by more than half, without the side effects that have ...
Study: Hormone-blocking drug cuts breast cancer riskPioneer Press
Study: Hormone-blocking drug reduces breast-cancer riskThe Seattle Times
New drug could help fight breast cancer6abc.com
Los Angeles Times -New York Times
all 493 news articles »
More...